Enzymatic Therapy Overview
- Status
-
Acquired/Merged
- Employees
-
280
- Latest Deal Type
-
M&A
- Financing Rounds
-
2
Enzymatic Therapy General Information
Description
Manufacturer and provider of therapeutic dosage natural medicines and nutritional supplements. The company was the first to introduce glucosamine sulfate, gingko biloba and many other products into the North American marketplace. The company was also the first in the United States to provide standardized active ingredients in its botanical products and to introduce phytozomes to aid consumers in absorbing active ingredients of ingested products.
Contact Information
Primary Industry
Pharmaceuticals
Other Industries
Food Products
Acquirer
The Dr. Willmar Schwabe Group
Primary Office
- 825 Challenger Drive
- Green Bay, WI 54311
- United States
+1 (920) 000-0000
Enzymatic Therapy Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Enzymatic Therapy Patents
Enzymatic Therapy Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| DE-59509134-D1 | Method for isomerizing spirocyclic beta-aminocarboxyl and beta-aminocarbonyl compounds | Inactive | 04-Feb-1994 | 0000000000 | |
| EP-0741727-A1 | Process for isomerization of spirocyclic compounds with $g(b)-aminocarboxyl and/or $g(b)-aminocarbonyl systems | Active | 04-Feb-1994 | 0000000000 | |
| EP-0741727-B1 | Process for isomerization of spirocyclic compounds with beta-aminocarboxyl and/or beta-aminocarbonyl systems | Inactive | 04-Feb-1994 | 0000000000 | |
| US-5723625-A | Isomerization according to defined pattern | Inactive | 04-Feb-1994 | C07D491/22 |
Enzymatic Therapy Board Members (2)
| Name | Representing | Role | Since |
|---|---|---|---|
| 000000 00000000 | Self | Board Officer | 000 0000 |
Enzymatic Therapy Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Enzymatic Therapy Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|